- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/79 - Benzo [b] furansHydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
Patent holdings for IPC class C07D 307/79
Total number of patents in this class: 542
10-year publication summary
|
29
|
39
|
46
|
26
|
32
|
28
|
39
|
31
|
35
|
21
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2712 |
14 |
| Autifony Therapeutics Limited | 51 |
13 |
| Bristol-myers Squibb Company | 4742 |
9 |
| Vanda Pharmaceuticals, Inc. | 386 |
9 |
| Sanofi | 4301 |
9 |
| Novartis AG | 10262 |
8 |
| Daewoong Pharmaceutical Co., Ltd. | 363 |
8 |
| LG Chem, Ltd. | 17921 |
7 |
| Idemitsu Kosan Co., Ltd. | 4235 |
7 |
| CHDI Foundation, Inc. | 107 |
7 |
| SFC Co., Ltd. | 335 |
7 |
| BASF SE | 21303 |
6 |
| Janssen Pharmaceutica N.V. | 3168 |
6 |
| Queen's University at Kingston | 538 |
6 |
| The Scripps Research Institute | 1344 |
6 |
| H. Lundbeck A/S | 1232 |
6 |
| Genentech, Inc. | 4104 |
5 |
| Merck Patent GmbH | 5728 |
5 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 308 |
5 |
| Medshine Discovery Inc. | 587 |
5 |
| Other owners | 394 |